Nestlé is using AI tools to develop new products for consumers taking GLP-1 treatments like Ozempic, Reuters reported. Chief Technology Officer Stefan Palzer called it a huge opportunity, noting that AI helps analyze clinical research for tailoring products to GLP-1 users. The company has patented ingredient combinations aimed at reducing appetite after discontinuation and added collagen protein to Vital Proteins to address skin, hair, and nail concerns. In the U.S., it launched Boost Advanced Nutritional Shake with 35 grams of protein, and rolled out Milo PRO High Protein in Asia and Australia. Nestlé is also testing AI-driven simulations to predict consumer responses and using AI to track social media trends.
Eli Lilly and Company
Novo Nordisk A/SNestle S.A.Nestlé uses AI to develop products for GLP-1 users, a new product opportunity.
CTO Realty Growth Inc